Medicines / Boehringer Ingelheim / Praxbind
PraxbindIdarucizumab
Praxbind is marketed by Boehringer Ingelheim. 1 pack on NPPA's price list for July 2026, containing Idarucizumab.
- Packs listed
- 1
- Lowest MRP
- ₹152,853
- Per unit
- ₹152,853
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹152,853Praxbind 50 mg Injection 1 mlIdarucizumab Injection 50 mg · ₹152,853 per ml
The company
Boehringer Ingelheim has 22 packs on the price list, and CDSCO has named it as the manufacturer of 1 failed batch since Aug 2022. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.